Actavis Elizabeth LLC’s suit against the U.S. Food and Drug Administration remains stayed, according to Shire Ltd.’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission.
On Feb. 24,…
Genzyme Corporation and its wholly owned subsidiary Bone Care International, LLC, pursue a Hectorol patent infringement complaint against Sandoz Inc.
In June 2009, the company received notice that Sandoz had submitted…
The U.S. District Court for the Western District of Texas, Austin Division, on September 24 returned a verdict in a suit brought by Western Union:
— finding MoneyGram International infringed on…
No trial date has been set for the litigation between Shire Ltd. and Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos.…
Genzyme Corporation is engaged in dispute with Sandoz, Inc., over infringement of the Renagel patent.
The company on July 2, 2009, filed a complaint against Sandoz in the U.S. District Court…
Genzyme Corporation’s patent infringement suit against Eagle Pharmaceuticals, Inc., remains pending in the U.S. District Court for the District of Delaware.
In March 2009, the company received notice that Eagle had…
Genzyme Corporation is pursuing an amended patent infringement complaint against Pentech Pharmaceuticals, Inc.
In January 2008, the company received notice that Pentech had submitted to the U.S. Food and Drug Administration…
Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.
Beginning in January 2009, the company received notices from…
Shire Ltd.’s suit against CorePharma LLC for the alleged infringement of U.S. Patent Nos. 5,912,013, was settled on July 14, 2009.
The patent-at-issue covers an advanced drug delivery system using carbamazepine.
On…
Shire Ltd. is pursuing two suits against Nostrum Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent Nos. 5,912,013…